AB-CHMINACA
AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 .
AB-FUBINACA was first synthesized by Pfizer, Inc. as a potent CB1 receptor modulator for potential therapeutic use, but recently was identified along with AB-PINACA in illegal herbal products.
AB-CHMINACA is structurally related to AB-FUBINACA with a cyclohexyl group substituted for the 4-fluorophenyl group.
The physiological and toxicological properties of this compound have not been determined.
This product is intended for research and forensic applications.
Technical Information
| Formal Name | N- |
| CAS Number | 1185887-21-1 |
| Molecular Formula | C20H28N4O2 |
| Formula Weight | 356.5 |
| Purity | ≥98% |
| Formulation | A crystalline solid |
| λmax | 210, 303 nm |
| SMILES | O=C(N[C@H](C(N)=O)C(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3 |
| InChI Code | InChI=1S/C20H28N4O2/c1-13(2)17(19(21)25)22-20(26)18-15-10-6-7-11-16(15)24(23-18)12-14-8-4-3-5-9-14/h6-7,10-11,13-14,17H,3-5,8-9,12H2,1-2H3,(H2,21,25)(H,22,26)/t17-/m0/s1 |
| InChI Key | KJNZIEGLNLCWTQ-KRWDZBQOSA-N |
Technical Information
| Formal Name | N- |
| CAS Number | 1185887-21-1 |
| Molecular Formula | C20H28N4O2 |
| Formula Weight | 356.5 |
| Purity | ≥98% |
| Formulation | A crystalline solid |
| λmax | 210, 303 nm |
| SMILES | O=C(N[C@H](C(N)=O)C(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3 |
| InChI Code | InChI=1S/C20H28N4O2/c1-13(2)17(19(21)25)22-20(26)18-15-10-6-7-11-16(15)24(23-18)12-14-8-4-3-5-9-14/h6-7,10-11,13-14,17H,3-5,8-9,12H2,1-2H3,(H2,21,25)(H,22,26)/t17-/m0/s1 |
| InChI Key | KJNZIEGLNLCWTQ-KRWDZBQOSA-N |
AB-FUBINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 .
AB-FUBINACA was first synthesized by Pfizer, Inc. as a potent CB1 receptor modulator for potential therapeutic use, but recently was identified along with AB-PINACA in illegal herbal products.
AB-CHMINACA is structurally related to AB-FUBINACA with a cyclohexyl group substituted for the 4-fluorophenyl group.
The physiological and toxicological properties of this compound have not been determined.
This product is intended for research and forensic applications.
Technical Information
| Formal Name | N- |
| CAS Number | 1185887-21-1 |
| Molecular Formula | C20H28N4O2 |
| Formula Weight | 356.5 |
| Purity | ≥98% |
| Formulation | A crystalline solid |
| λmax | 210, 303 nm |
| SMILES | O=C(N[C@H](C(N)=O)C(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3 |
| InChI Code | InChI=1S/C20H28N4O2/c1-13(2)17(19(21)25)22-20(26)18-15-10-6-7-11-16(15)24(23-18)12-14-8-4-3-5-9-14/h6-7,10-11,13-14,17H,3-5,8-9,12H2,1-2H3,(H2,21,25)(H,22,26)/t17-/m0/s1 |
| InChI Key | KJNZIEGLNLCWTQ-KRWDZBQOSA-N |
Technical Information
| Formal Name | N- |
| CAS Number | 1185887-21-1 |
| Molecular Formula | C20H28N4O2 |
| Formula Weight | 356.5 |
| Purity | ≥98% |
| Formulation | A crystalline solid |
| λmax | 210, 303 nm |
| SMILES | O=C(N[C@H](C(N)=O)C(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3 |
| InChI Code | InChI=1S/C20H28N4O2/c1-13(2)17(19(21)25)22-20(26)18-15-10-6-7-11-16(15)24(23-18)12-14-8-4-3-5-9-14/h6-7,10-11,13-14,17H,3-5,8-9,12H2,1-2H3,(H2,21,25)(H,22,26)/t17-/m0/s1 |
| InChI Key | KJNZIEGLNLCWTQ-KRWDZBQOSA-N |
4F-PVP Crystals 4F-PVP Crystals 4f-pvp is also referred to as 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone by ACD/IUPAC, 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one, 1-pentanone,…
25I-NBF 25I-NBF 25I-NBF is an N-benzyl derivative of the phenethylamine hallucinogen 2C-I which acts as…
Isopropylphenidate Crystals/Powder Isopropylphenidate Crystals/Powder Description: ProductName: Isopropylphenidate Cas No: 93148-46-0 Formula: C16H23NO2 Appearance: powder Purity:above 99.5 % Isopropylphenidate (also…
6-APB 6-APB 6-(2-aminopropyl)benzofuran (also known as 6-APB or by the brand-name Benzofury) is a popular…
5F-PB22 Description 5F-PB22 Features This product has been manufactured and tested to meet ISO17025:2005 and…
3F-MEO-PCP 3F-MEO-PCP 2′-Oxo-PCE (also known as O-PCE and eticyclidone) is a new dissociative NMDA receptor…